Fortress Biotech (FBIO) EBIAT (2016 - 2025)
Historic EBIAT for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $8.8 million.
- Fortress Biotech's EBIAT rose 13306.74% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.7 million, marking a year-over-year increase of 7839.06%. This contributed to the annual value of -$120.9 million for FY2024, which is 2160.11% up from last year.
- Fortress Biotech's EBIAT amounted to $8.8 million in Q3 2025, which was up 13306.74% from $15.5 million recorded in Q2 2025.
- Fortress Biotech's 5-year EBIAT high stood at $15.5 million for Q2 2025, and its period low was -$68.5 million during Q4 2021.
- Its 5-year average for EBIAT is -$32.7 million, with a median of -$28.8 million in 2024.
- As far as peak fluctuations go, Fortress Biotech's EBIAT tumbled by 23434.85% in 2021, and later surged by 15372.61% in 2025.
- Over the past 5 years, Fortress Biotech's EBIAT (Quarter) stood at -$68.5 million in 2021, then rose by 16.15% to -$57.4 million in 2022, then surged by 49.54% to -$29.0 million in 2023, then increased by 9.21% to -$26.3 million in 2024, then skyrocketed by 133.54% to $8.8 million in 2025.
- Its last three reported values are $8.8 million in Q3 2025, $15.5 million for Q2 2025, and -$24.7 million during Q1 2025.